Technologies like artificial intelligence (AI) and machine learning are now shaping the future of the life sciences industry – and data is the foundation that drives these technologies forward. However, without the right tools to help manage and process it, the best data in the world can quickly become useless.

• As the entire industry evolves to embrace patient data, what are healthcare stakeholders getting right? What are they getting wrong?
• What are the biggest challenges to centralizing, standardizing, and managing data? How are you tackling those challenges?
• What do you see as the next frontier when it comes to data-driven solutions? What are the tools being developed right now that will transform the way we approach healthcare?
• What role does AI play in your company’s operations? Where do you see the most potential for healthcare to benefit from the current AI tide?

• Building enhanced RWE capabilities to maximize data generation
• Harnessing data sources with the use of novel technologies
• Key considerations for RWE strategy to demonstrate value to regulators
• Navigating the RWE regulatory landscape to gain market access on a global scale
• Enhancing clinical trials and meet unmet patient needs

We have all the tools to make healthcare fairer and more equitable, but is it being deployed properly? Are we leveraging these tools? Is politics getting in the way?

• The promise of healthtech to improve health equity and access to care
• What technology is required to increase health equity in communities across the nation?
• Has commercial scalability caught up with equitable innovations?
• What are the missing tools in the toolkit?
• Pushing past the politics and making health equity a reality – What is the best way to do this?

• Investor perspective- building a thriving ecosystem that combines startups from all three verticals
• Going beyond ‘AI in drug discovery’ and bridging the gap between Healthtech & Biopharma
• Discussing how the integration of digital and medical technologies is enhancing diagnostics and monitoring
• Data – How is the industry leveraging all the patient data whilst addressing privacy concerns?
• Real-world examples of personalized care facilitated by this convergence

• Understanding what CVCs are looking for in when looking to invest in digital health & MedTech innovators
• What factors are driving your investment decisions, and which areas are primed for growth?
• Striking the right balance - aligning strategic and financial interests
• Analysis of the current valuation environment for digital health and MedTech startups

The outcome of the 2024 Presidential Election in the United States has the potential to significantly impact the healthcare and life sciences sector, shaping policies, regulations, and funding priorities for years to come. With broader issues such as healthcare accessibility, affordability, and innovation, the decisions made by the incoming administration will have far-reaching consequences for stakeholders across the industry. This panel discussion seeks to explore the potential implications of the election outcome on the healthcare and life sciences sector, examining key areas of impact and identifying strategies for navigating the evolving landscape.

• Potential impact on drug pricing, approval and insurance
• For medical devices, will stricter regulations create a fallout akin to the MDR in Europe?
• Impact of cyber-security and AI legislation on digital health innovation and implementation

The healthcare industry continues to be a hotbed of innovation and investment, with a diverse range of players contributing to its vibrancy. What future trends are on the horizon and how can the industry continue to move forward as a cohesive sector, play to each other’s strengths, and ensure we move into 2025 informed and continue to bring proactive and preventative treatments to patients.

• Understanding the patient – how will people manage their own health risks in 2025?
• Has AI delivered for healthcare in 2024?
• What can help partnerships to thrive?
• What future trends can we expect to see and what are the trends we can expect to forget?